(Q54439849)
Statements
Phase I and pharmacokinetic study of bexarotene in combination with gefitinib in the third-line treatment of non-small-cell lung cancer: brief report. (English)
Sukhmani K Padda
Laveena Chhatwani
Lisa Zhou
Charlotte D Jacobs
Arturo Lopez-Anaya
Heather A Wakelee
1 August 2013
24
7
731-735